DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Acetaminophen; hydrocodone bitartrateis the generic ingredient in twenty-one branded drugs marketed by Cent Pharms, Ivax Pharms, Forest Pharms, Mallinckrodt, Mikart, Anda Repository, Genus, Mallinckrodt Inc, Nesher Pharms, Pharm Assoc, Vintage Pharms, Vistapharm, Wes Pharma Inc, Cypress Pharm Inc, Specgx Llc, Ucb Inc, Ascher, Abhai Llc, Able, Actavis Labs Fl Inc, Alvogen Pine Brook, Amneal Pharms, Amneal Pharms Ny, Apil, Ascent Pharms Inc, Aurolife Pharma Llc, Barr, Caraco, Cerovene Inc, Epic Pharma Llc, Granules Pharms, Halsey, Lannett Co Inc, Mutual Pharm, Nostrum Labs Inc, Novel Labs Inc, Par Pharm, Ranbaxy, Ranbaxy Labs Ltd, Rhodes Pharms, Sandoz, Sun Pharm Inds Inc, Sun Pharm Inds Ltd, Tris Pharma Inc, Upsher Smith Labs, Usl Pharma, Vintage Pharms Llc, Watson Labs, Watson Labs Florida, Abana, Ortho Mcneil Pharm, Abbott, and Abbvie, and is included in one hundred and forty-eight NDAs. Additional information is available in the individual branded drug profile pages.
There are sixty-six drug master file entries for acetaminophen; hydrocodone bitartrate. Forty-one suppliers are listed for this compound.
Recent Clinical Trials for acetaminophen; hydrocodone bitartrate
Identify potential brand extensions & 505(b)(2) entrants
|Sun Pharma Advanced Research Company Limited||Phase 1|
|Grünenthal GmbH||Phase 1|
|Teva Branded Pharmaceutical Products, R&D Inc.||Phase 3|
Pharmacology for acetaminophen; hydrocodone bitartrate
|Drug Class||Opioid Agonist |
|Mechanism of Action||Opioid Agonists |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Mallinckrodt||HYDROCODONE BITARTRATE AND ACETAMINOPHEN||acetaminophen; hydrocodone bitartrate||TABLET;ORAL||040084-004||Oct 16, 1996||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Vintage Pharms||HYDROCODONE BITARTRATE AND ACETAMINOPHEN||acetaminophen; hydrocodone bitartrate||TABLET;ORAL||040144-001||Feb 22, 1996||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Rhodes Pharms||HYDROCODONE BITARTRATE AND ACETAMINOPHEN||acetaminophen; hydrocodone bitartrate||TABLET;ORAL||207808-002||Mar 30, 2018||AA||RX||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.